Method for preparing losartan potassium and hydrochlorothiazide composition

A technology for losartan potassium hydrochlorothiazide and losartan potassium is applied in the field of preparation of pharmaceutical preparations for treating hypertension, and can solve the problems of curative effect and safety risks, instability of hydrochlorothiazide, quality reduction of hydrochlorothiazide tablets, etc.

Active Publication Date: 2014-01-15
BEIJING WINSUNNY PHARMA CO LTD
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In this method, losartan potassium and hydrochlorothiazide are granulated separately, and then mixed and compressed into tablets, which reduces the chance of contacting hydrochlorothiazide with losartan potassium and other auxiliary mat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing losartan potassium and hydrochlorothiazide composition
  • Method for preparing losartan potassium and hydrochlorothiazide composition
  • Method for preparing losartan potassium and hydrochlorothiazide composition

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0032] Example 1

[0033] (1) Mix 50 g of losartan potassium, 80 g of microcrystalline cellulose, 20 g of lactose, and 5 g of croscarmellose sodium, and dry granulate to obtain drug granules a containing losartan potassium;

[0034] (2) Mix 12.5g hydrochlorothiazide, 70g pregelatinized starch, 40g microcrystalline cellulose, 3g povidone, and 3g carboxymethyl starch sodium, and dry granulate to obtain drug granules b containing hydrochlorothiazide;

[0035] (3) Dissolve an appropriate amount of polymethacrylate in water to make a coating solution;

[0036] (4) Put the drug granule b in the coating machine, and spray the coating solution when the temperature in the coating machine reaches 40-45°C,

[0037] Screen 20-40 mesh particles, that is, coated particles c;

[0038] (5) Mix drug granules a and coating granules c evenly, add magnesium stearate, compress into tablets or pack into capsules.

Example Embodiment

[0039] Example 2

[0040]

[0041] Preparation method is the same as embodiment 1

Example Embodiment

[0042] Example 3

[0043]

[0044] Preparation method is the same as embodiment 1

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for preparing a losartan potassium and hydrochlorothiazide composition. The method comprises the following steps: respectively carrying out dry granulation of losartan potassium and hydrochlorothiazide, coating above dry-granulated hydrochlorothiazide, uniformly mixing above obtained losartan potassium particles with the above coated hydrochlorothiazide particles, and tabletting or filling into capsules. The method can effectively control the content of relevant substances, guarantees the content uniformity of main drugs, reduces untoward effects, and realizes a good pressure reducing effect.

Description

field of invention [0001] The invention relates to a preparation method of a drug preparation for treating hypertension, in particular to a preparation method of a losartan potassium hydrochlorothiazide composition. Background technique [0002] Hypertension is a chronic disease characterized by continuous elevation of arterial blood pressure, which often causes lesions in heart, brain, kidney and other important organs with corresponding consequences. The treatment of hypertension requires long-term medication. Generally, it starts with a small dose and gradually increases the dose. There are generally three countermeasures for patients whose blood pressure cannot be controlled after receiving a drug treatment. One is to increase the dose of the original drug, but there will be It may lead to the consequence that the antihypertensive effect is not enhanced and the adverse reactions increase; the second is to switch to another drug, but if the effect after changing the drug ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/549A61K9/20A61K9/48A61K9/16A61P9/12A61K31/4178
Inventor 耿玉先产运霞
Owner BEIJING WINSUNNY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap